Hanson & Doremus Investment Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Sell
6,435
-100
-2% -$2.41K 0.02% 218
2025
Q4
$158K Buy
6,535
+60
+0.9% +$1.45K 0.02% 216
2025
Q3
$156K Buy
+6,475
New +$156K 0.02% 220

Other funds holding IBD

Hanson & Doremus Investment Management's IBD Position: Q1 2026 in Review

Hanson & Doremus Investment Management reduced its Inspire Corporate Bond ETF (IBD) stake by 1.5% in Q1 2026, selling an estimated $2.41K and leaving 6,435 shares worth $154K. The position accounts for 0.02% of the portfolio, ranked #218.

Hanson & Doremus Investment Management first reported a position in IBD in Q3 2025 and has held it in 3 quarters since. The position peaked at $158K in Q4 2025. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • Hanson & Doremus Investment Management held 6,435 shares of Inspire Corporate Bond ETF worth $154K as of Q1 2026.
  • Hanson & Doremus Investment Management sold 100 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $2.41K.
  • Inspire Corporate Bond ETF made up 0.02% of Hanson & Doremus Investment Management's portfolio in Q1 2026, its #218 holding.
  • Hanson & Doremus Investment Management first reported a position in Inspire Corporate Bond ETF in Q3 2025 and has held it in 3 quarters since.
  • Hanson & Doremus Investment Management's Inspire Corporate Bond ETF position peaked at $158K in Q4 2025.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2026, filed 17 Apr 2026.